<ARTICLE> 5 <LEGEND> IMMUCELL CORPORATION Exhibit 27.1 Financial Data Schedule THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S UNAUDITED FINANCIAL STATEMENTS FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1997 AS REPORTED ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-END> JUN-30-1997 <CASH> 931,573 <SECURITIES> 0 <RECEIVABLES> 348,921 <ALLOWANCES> (53,758) <INVENTORY> 569,592 <CURRENT-ASSETS> 1,878,895 <PP&E> 1,458,465 <DEPRECIATION> 666,874 <TOTAL-ASSETS> 2,912,995 <CURRENT-LIABILITIES> 636,131 <BONDS> 446,273 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 1,830,591 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 2,912,995 <SALES> 2,045,874 <TOTAL-REVENUES> 2,147,755 <CGS> 913,860 <TOTAL-COSTS> 2,183,626 <OTHER-EXPENSES> (20,297) <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 36,892 <INCOME-PRETAX> (52,466) <INCOME-TAX> 0 <INCOME-CONTINUING> (52,466) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (52,466) <EPS-PRIMARY> (.02) <EPS-DILUTED> (.02)